Clinical trial
Irinotecan in Treating Children With Refractory or Advanced Solid Tumors Who Are…
NCT00008424 · Children's Oncology Group, Other · Completed
Key facts
| NCT number | NCT00008424 |
|---|---|
| Title | Irinotecan in Treating Children With Refractory or Advanced Solid Tumors Who Are Receiving Anticonvulsants |
| Official title | A Phase I Study of Irinotecan in Patients With Refractory Solid Tumors Who Are Concomitantly Receiving Anticonvulsants |
| Lead sponsor | Children's Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Childhood Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | irinotecan hydrochloride |
| Enrollment | 7 |
| Start date | Oct 1, 2000 |
| Primary completion | Sep 1, 2005 |
| Completion | Sep 1, 2006 |
| First posted | Jun 5, 2003 |
| Last update posted | May 5, 2014 |
| Countries | Australia, Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: